Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
2,621
archived clinical trials in
Urology

Efficacy and Safety of S-Equol on Men With Benign Prostatic Hyperplasia
Randomized, Double Blind, Multicenter, Placebo Controlled, Proof of Concept Trial to Assess the Efficacy and Safety of 4 Weeks Treatment With AUS 131 (S Equol) on Benign Prostatic Hyperplasia
Status: Enrolling
Updated:  1/8/2016
Medical Affiliated Research Center, Inc.
411
mi
from 43215
Huntsville, AL
Efficacy and Safety of S-Equol on Men With Benign Prostatic Hyperplasia
Randomized, Double Blind, Multicenter, Placebo Controlled, Proof of Concept Trial to Assess the Efficacy and Safety of 4 Weeks Treatment With AUS 131 (S Equol) on Benign Prostatic Hyperplasia
Status: Enrolling
Updated: 1/8/2016
Medical Affiliated Research Center, Inc.
411
mi
from 43215
Huntsville, AL
Click here to add this to my saved trials
Efficacy and Safety of S-Equol on Men With Benign Prostatic Hyperplasia
Randomized, Double Blind, Multicenter, Placebo Controlled, Proof of Concept Trial to Assess the Efficacy and Safety of 4 Weeks Treatment With AUS 131 (S Equol) on Benign Prostatic Hyperplasia
Status: Enrolling
Updated:  1/8/2016
South Florida Medical Research
982
mi
from 43215
Aventura, FL
Efficacy and Safety of S-Equol on Men With Benign Prostatic Hyperplasia
Randomized, Double Blind, Multicenter, Placebo Controlled, Proof of Concept Trial to Assess the Efficacy and Safety of 4 Weeks Treatment With AUS 131 (S Equol) on Benign Prostatic Hyperplasia
Status: Enrolling
Updated: 1/8/2016
South Florida Medical Research
982
mi
from 43215
Aventura, FL
Click here to add this to my saved trials
Efficacy and Safety of S-Equol on Men With Benign Prostatic Hyperplasia
Randomized, Double Blind, Multicenter, Placebo Controlled, Proof of Concept Trial to Assess the Efficacy and Safety of 4 Weeks Treatment With AUS 131 (S Equol) on Benign Prostatic Hyperplasia
Status: Enrolling
Updated:  1/8/2016
Tampa Bay Medical Research Inc.
824
mi
from 43215
Clearwater, FL
Efficacy and Safety of S-Equol on Men With Benign Prostatic Hyperplasia
Randomized, Double Blind, Multicenter, Placebo Controlled, Proof of Concept Trial to Assess the Efficacy and Safety of 4 Weeks Treatment With AUS 131 (S Equol) on Benign Prostatic Hyperplasia
Status: Enrolling
Updated: 1/8/2016
Tampa Bay Medical Research Inc.
824
mi
from 43215
Clearwater, FL
Click here to add this to my saved trials
Efficacy and Safety of S-Equol on Men With Benign Prostatic Hyperplasia
Randomized, Double Blind, Multicenter, Placebo Controlled, Proof of Concept Trial to Assess the Efficacy and Safety of 4 Weeks Treatment With AUS 131 (S Equol) on Benign Prostatic Hyperplasia
Status: Enrolling
Updated:  1/8/2016
Advanced Clinical Research
1519
mi
from 43215
West Jordon, UT
Efficacy and Safety of S-Equol on Men With Benign Prostatic Hyperplasia
Randomized, Double Blind, Multicenter, Placebo Controlled, Proof of Concept Trial to Assess the Efficacy and Safety of 4 Weeks Treatment With AUS 131 (S Equol) on Benign Prostatic Hyperplasia
Status: Enrolling
Updated: 1/8/2016
Advanced Clinical Research
1519
mi
from 43215
West Jordon, UT
Click here to add this to my saved trials
Efficacy and Safety of S-Equol on Men With Benign Prostatic Hyperplasia
Randomized, Double Blind, Multicenter, Placebo Controlled, Proof of Concept Trial to Assess the Efficacy and Safety of 4 Weeks Treatment With AUS 131 (S Equol) on Benign Prostatic Hyperplasia
Status: Enrolling
Updated:  1/8/2016
Clinical Research Associates of Tidewater
422
mi
from 43215
Norfolk, VA
Efficacy and Safety of S-Equol on Men With Benign Prostatic Hyperplasia
Randomized, Double Blind, Multicenter, Placebo Controlled, Proof of Concept Trial to Assess the Efficacy and Safety of 4 Weeks Treatment With AUS 131 (S Equol) on Benign Prostatic Hyperplasia
Status: Enrolling
Updated: 1/8/2016
Clinical Research Associates of Tidewater
422
mi
from 43215
Norfolk, VA
Click here to add this to my saved trials
Efficacy and Safety of S-Equol on Men With Benign Prostatic Hyperplasia
Randomized, Double Blind, Multicenter, Placebo Controlled, Proof of Concept Trial to Assess the Efficacy and Safety of 4 Weeks Treatment With AUS 131 (S Equol) on Benign Prostatic Hyperplasia
Status: Enrolling
Updated:  1/8/2016
Samved Hospital
7808
mi
from 43215
Ahmedabad,
Efficacy and Safety of S-Equol on Men With Benign Prostatic Hyperplasia
Randomized, Double Blind, Multicenter, Placebo Controlled, Proof of Concept Trial to Assess the Efficacy and Safety of 4 Weeks Treatment With AUS 131 (S Equol) on Benign Prostatic Hyperplasia
Status: Enrolling
Updated: 1/8/2016
Samved Hospital
7808
mi
from 43215
Ahmedabad,
Click here to add this to my saved trials
Early or Late Foley Removal After Thoracotomy
Optimal Timing of Foley Catheter Removal in Patients Undergoing Thoracic Surgery With Epidural Analgesia: A Randomized, Controlled Trial
Status: Enrolling
Updated:  1/12/2016
Mayo Clinic Rochester
559
mi
from 43215
Rochester, MN
Early or Late Foley Removal After Thoracotomy
Optimal Timing of Foley Catheter Removal in Patients Undergoing Thoracic Surgery With Epidural Analgesia: A Randomized, Controlled Trial
Status: Enrolling
Updated: 1/12/2016
Mayo Clinic Rochester
559
mi
from 43215
Rochester, MN
Click here to add this to my saved trials
Intravaginal LACTIN-V for Prevention of Recurrent Urinary Tract Infection
Intravaginal LACTIN-V for Prevention of Recurrent Urinary Tract Infections
Status: Enrolling
Updated:  1/13/2016
Hall Health Primary Care Center, University of Washington
2006
mi
from 43215
Seattle, WA
Intravaginal LACTIN-V for Prevention of Recurrent Urinary Tract Infection
Intravaginal LACTIN-V for Prevention of Recurrent Urinary Tract Infections
Status: Enrolling
Updated: 1/13/2016
Hall Health Primary Care Center, University of Washington
2006
mi
from 43215
Seattle, WA
Click here to add this to my saved trials
A Clinical Study to Assess the Safety of a Disposable Intra-vaginal Device for Stress Urinary Incontinence
A Clinical Study to Assess the Safety of a Disposable Intra-vaginal Device for Stress Urinary Incontinence
Status: Enrolling
Updated:  1/15/2016
Study Center
1654
mi
from 43215
Chandler, AZ
A Clinical Study to Assess the Safety of a Disposable Intra-vaginal Device for Stress Urinary Incontinence
A Clinical Study to Assess the Safety of a Disposable Intra-vaginal Device for Stress Urinary Incontinence
Status: Enrolling
Updated: 1/15/2016
Study Center
1654
mi
from 43215
Chandler, AZ
Click here to add this to my saved trials
Cranberry Proanthocyanidins for Modification of Intestinal E. Coli Flora and Prevention of Urinary Tract Infections in UTI-Susceptible Women
Cranberry Proanthocyanidins for Modification of Intestinal E. Coli Flora and Prevention of Urinary Tract Infections in UTI-Susceptible Women
Status: Enrolling
Updated:  1/28/2016
University of Wisconsin-Madison
394
mi
from 43215
Madison, WI
Cranberry Proanthocyanidins for Modification of Intestinal E. Coli Flora and Prevention of Urinary Tract Infections in UTI-Susceptible Women
Cranberry Proanthocyanidins for Modification of Intestinal E. Coli Flora and Prevention of Urinary Tract Infections in UTI-Susceptible Women
Status: Enrolling
Updated: 1/28/2016
University of Wisconsin-Madison
394
mi
from 43215
Madison, WI
Click here to add this to my saved trials
Ceftazidime-Avibactam Compared With Doripenem Followed by Oral Therapy for Hospitalized Adults With Complicated UTIs (Urinary Tract Infections)
A Phase III, Randomized, Multicenter, Double-Blind, Double Dummy, Parallel Group, Comparative Study to Determine the Efficacy, Safety, and Tolerability of Ceftazidime Avibactam (CAZ-AVI, Formerly CAZ104) Versus Doripenem Followed by Appropriate Oral Therapy in the Treatment of Complicated Urinary Tract Infections, Including Acute Pyelonephritis, With a Gram Negative Pathogen in Hospitalized Adults
Status: Enrolling
Updated:  2/3/2016
Clinical Research Facility
163
mi
from 43215
Detroit, MI
Ceftazidime-Avibactam Compared With Doripenem Followed by Oral Therapy for Hospitalized Adults With Complicated UTIs (Urinary Tract Infections)
A Phase III, Randomized, Multicenter, Double-Blind, Double Dummy, Parallel Group, Comparative Study to Determine the Efficacy, Safety, and Tolerability of Ceftazidime Avibactam (CAZ-AVI, Formerly CAZ104) Versus Doripenem Followed by Appropriate Oral Therapy in the Treatment of Complicated Urinary Tract Infections, Including Acute Pyelonephritis, With a Gram Negative Pathogen in Hospitalized Adults
Status: Enrolling
Updated: 2/3/2016
Clinical Research Facility
163
mi
from 43215
Detroit, MI
Click here to add this to my saved trials
Ceftazidime-Avibactam Compared With Doripenem Followed by Oral Therapy for Hospitalized Adults With Complicated UTIs (Urinary Tract Infections)
A Phase III, Randomized, Multicenter, Double-Blind, Double Dummy, Parallel Group, Comparative Study to Determine the Efficacy, Safety, and Tolerability of Ceftazidime Avibactam (CAZ-AVI, Formerly CAZ104) Versus Doripenem Followed by Appropriate Oral Therapy in the Treatment of Complicated Urinary Tract Infections, Including Acute Pyelonephritis, With a Gram Negative Pathogen in Hospitalized Adults
Status: Enrolling
Updated:  2/3/2016
Clinical Research Facility
395
mi
from 43215
St. Louis, MO
Ceftazidime-Avibactam Compared With Doripenem Followed by Oral Therapy for Hospitalized Adults With Complicated UTIs (Urinary Tract Infections)
A Phase III, Randomized, Multicenter, Double-Blind, Double Dummy, Parallel Group, Comparative Study to Determine the Efficacy, Safety, and Tolerability of Ceftazidime Avibactam (CAZ-AVI, Formerly CAZ104) Versus Doripenem Followed by Appropriate Oral Therapy in the Treatment of Complicated Urinary Tract Infections, Including Acute Pyelonephritis, With a Gram Negative Pathogen in Hospitalized Adults
Status: Enrolling
Updated: 2/3/2016
Clinical Research Facility
395
mi
from 43215
St. Louis, MO
Click here to add this to my saved trials
Ceftazidime-Avibactam Compared With Doripenem Followed by Oral Therapy for Hospitalized Adults With Complicated UTIs (Urinary Tract Infections)
A Phase III, Randomized, Multicenter, Double-Blind, Double Dummy, Parallel Group, Comparative Study to Determine the Efficacy, Safety, and Tolerability of Ceftazidime Avibactam (CAZ-AVI, Formerly CAZ104) Versus Doripenem Followed by Appropriate Oral Therapy in the Treatment of Complicated Urinary Tract Infections, Including Acute Pyelonephritis, With a Gram Negative Pathogen in Hospitalized Adults
Status: Enrolling
Updated:  2/3/2016
Clinical Research Facility
208
mi
from 43215
Indiana, PA
Ceftazidime-Avibactam Compared With Doripenem Followed by Oral Therapy for Hospitalized Adults With Complicated UTIs (Urinary Tract Infections)
A Phase III, Randomized, Multicenter, Double-Blind, Double Dummy, Parallel Group, Comparative Study to Determine the Efficacy, Safety, and Tolerability of Ceftazidime Avibactam (CAZ-AVI, Formerly CAZ104) Versus Doripenem Followed by Appropriate Oral Therapy in the Treatment of Complicated Urinary Tract Infections, Including Acute Pyelonephritis, With a Gram Negative Pathogen in Hospitalized Adults
Status: Enrolling
Updated: 2/3/2016
Clinical Research Facility
208
mi
from 43215
Indiana, PA
Click here to add this to my saved trials
Ceftazidime-Avibactam Compared With Doripenem Followed by Oral Therapy for Hospitalized Adults With Complicated UTIs (Urinary Tract Infections)
A Phase III, Randomized, Multicenter, Double-Blind, Double Dummy, Parallel Group, Comparative Study to Determine the Efficacy, Safety, and Tolerability of Ceftazidime Avibactam (CAZ-AVI, Formerly CAZ104) Versus Doripenem Followed by Appropriate Oral Therapy in the Treatment of Complicated Urinary Tract Infections, Including Acute Pyelonephritis, With a Gram Negative Pathogen in Hospitalized Adults
Status: Enrolling
Updated:  2/3/2016
Research Site
mi
from 43215
Rosario,
Ceftazidime-Avibactam Compared With Doripenem Followed by Oral Therapy for Hospitalized Adults With Complicated UTIs (Urinary Tract Infections)
A Phase III, Randomized, Multicenter, Double-Blind, Double Dummy, Parallel Group, Comparative Study to Determine the Efficacy, Safety, and Tolerability of Ceftazidime Avibactam (CAZ-AVI, Formerly CAZ104) Versus Doripenem Followed by Appropriate Oral Therapy in the Treatment of Complicated Urinary Tract Infections, Including Acute Pyelonephritis, With a Gram Negative Pathogen in Hospitalized Adults
Status: Enrolling
Updated: 2/3/2016
Research Site
mi
from 43215
Rosario,
Click here to add this to my saved trials
A Study Evaluating the Efficacy and Safety of BOTOX® or Solifenacin in Patients With Overactive Bladder and Urinary Incontinence
Status: Enrolling
Updated:  2/8/2016
Clinical Research Facility
1963
mi
from 43215
Newport Beach, CA
A Study Evaluating the Efficacy and Safety of BOTOX® or Solifenacin in Patients With Overactive Bladder and Urinary Incontinence
Status: Enrolling
Updated: 2/8/2016
Clinical Research Facility
1963
mi
from 43215
Newport Beach, CA
Click here to add this to my saved trials
A Study Evaluating the Efficacy and Safety of BOTOX® or Solifenacin in Patients With Overactive Bladder and Urinary Incontinence
Status: Enrolling
Updated:  2/8/2016
4064
mi
from 43215
Leuven,
A Study Evaluating the Efficacy and Safety of BOTOX® or Solifenacin in Patients With Overactive Bladder and Urinary Incontinence
Status: Enrolling
Updated: 2/8/2016
4064
mi
from 43215
Leuven,
Click here to add this to my saved trials
Laparoscopic Pyeloplasty Registry and Database
Laparoscopic Pyeloplasty: A Registry and Database
Status: Enrolling
Updated:  2/22/2016
IU Health Methodist Hospital
166
mi
from 43215
Indianapolis, IN
Laparoscopic Pyeloplasty Registry and Database
Laparoscopic Pyeloplasty: A Registry and Database
Status: Enrolling
Updated: 2/22/2016
IU Health Methodist Hospital
166
mi
from 43215
Indianapolis, IN
Click here to add this to my saved trials
A Pilot Clinical Study of the Efficacy and Safety of a Disposable Intravaginal Device for Stress Urinary Incontinence
A Pilot Clinical Study of the Efficacy and Safety of a Disposable Intravaginal Device for Stress Urinary Incontinence
Status: Enrolling
Updated:  2/23/2016
Study Center
1654
mi
from 43215
Chandler, AZ
A Pilot Clinical Study of the Efficacy and Safety of a Disposable Intravaginal Device for Stress Urinary Incontinence
A Pilot Clinical Study of the Efficacy and Safety of a Disposable Intravaginal Device for Stress Urinary Incontinence
Status: Enrolling
Updated: 2/23/2016
Study Center
1654
mi
from 43215
Chandler, AZ
Click here to add this to my saved trials
A Clinical Study of the Effectiveness and Safety of a Disposable Intra-vaginal Device for Stress Urinary Incontinence (SUI)
A Clinical Study of the Effectiveness and Safety of a Disposable Intra-vaginal Device for Stress Urinary Incontinence
Status: Enrolling
Updated:  2/23/2016
Study Center
1654
mi
from 43215
Chandler, AZ
A Clinical Study of the Effectiveness and Safety of a Disposable Intra-vaginal Device for Stress Urinary Incontinence (SUI)
A Clinical Study of the Effectiveness and Safety of a Disposable Intra-vaginal Device for Stress Urinary Incontinence
Status: Enrolling
Updated: 2/23/2016
Study Center
1654
mi
from 43215
Chandler, AZ
Click here to add this to my saved trials
Ceftazidime-Avibactam Compared With Doripenem Followed by Oral Therapy for Hospitalized Adults With Complicated UTIs (Urinary Tract Infections)
A Phase III, Randomized, Multicenter, Double-Blind, Double Dummy, Parallel Group, Comparative Study to Determine the Efficacy, Safety, and Tolerability of Ceftazidime Avibactam (CAZ-AVI, Formerly CAZ104) Versus Doripenem Followed by Appropriate Oral Therapy in the Treatment of Complicated Urinary Tract Infections, Including Acute Pyelonephritis, With a Gram Negative Pathogen in Hospitalized Adults
Status: Enrolling
Updated:  3/8/2016
Clinical Research Facility
1976
mi
from 43215
Sylmar, CA
Ceftazidime-Avibactam Compared With Doripenem Followed by Oral Therapy for Hospitalized Adults With Complicated UTIs (Urinary Tract Infections)
A Phase III, Randomized, Multicenter, Double-Blind, Double Dummy, Parallel Group, Comparative Study to Determine the Efficacy, Safety, and Tolerability of Ceftazidime Avibactam (CAZ-AVI, Formerly CAZ104) Versus Doripenem Followed by Appropriate Oral Therapy in the Treatment of Complicated Urinary Tract Infections, Including Acute Pyelonephritis, With a Gram Negative Pathogen in Hospitalized Adults
Status: Enrolling
Updated: 3/8/2016
Clinical Research Facility
1976
mi
from 43215
Sylmar, CA
Click here to add this to my saved trials
Ceftazidime-Avibactam Compared With Doripenem Followed by Oral Therapy for Hospitalized Adults With Complicated UTIs (Urinary Tract Infections)
A Phase III, Randomized, Multicenter, Double-Blind, Double Dummy, Parallel Group, Comparative Study to Determine the Efficacy, Safety, and Tolerability of Ceftazidime Avibactam (CAZ-AVI, Formerly CAZ104) Versus Doripenem Followed by Appropriate Oral Therapy in the Treatment of Complicated Urinary Tract Infections, Including Acute Pyelonephritis, With a Gram Negative Pathogen in Hospitalized Adults
Status: Enrolling
Updated:  3/8/2016
Clinical Research Facility
176
mi
from 43215
Royal Oak, MI
Ceftazidime-Avibactam Compared With Doripenem Followed by Oral Therapy for Hospitalized Adults With Complicated UTIs (Urinary Tract Infections)
A Phase III, Randomized, Multicenter, Double-Blind, Double Dummy, Parallel Group, Comparative Study to Determine the Efficacy, Safety, and Tolerability of Ceftazidime Avibactam (CAZ-AVI, Formerly CAZ104) Versus Doripenem Followed by Appropriate Oral Therapy in the Treatment of Complicated Urinary Tract Infections, Including Acute Pyelonephritis, With a Gram Negative Pathogen in Hospitalized Adults
Status: Enrolling
Updated: 3/8/2016
Clinical Research Facility
176
mi
from 43215
Royal Oak, MI
Click here to add this to my saved trials
Ceftazidime-Avibactam Compared With Doripenem Followed by Oral Therapy for Hospitalized Adults With Complicated UTIs (Urinary Tract Infections)
A Phase III, Randomized, Multicenter, Double-Blind, Double Dummy, Parallel Group, Comparative Study to Determine the Efficacy, Safety, and Tolerability of Ceftazidime Avibactam (CAZ-AVI, Formerly CAZ104) Versus Doripenem Followed by Appropriate Oral Therapy in the Treatment of Complicated Urinary Tract Infections, Including Acute Pyelonephritis, With a Gram Negative Pathogen in Hospitalized Adults
Status: Enrolling
Updated:  3/8/2016
Clinical Research Facility
78
mi
from 43215
Lima, OH
Ceftazidime-Avibactam Compared With Doripenem Followed by Oral Therapy for Hospitalized Adults With Complicated UTIs (Urinary Tract Infections)
A Phase III, Randomized, Multicenter, Double-Blind, Double Dummy, Parallel Group, Comparative Study to Determine the Efficacy, Safety, and Tolerability of Ceftazidime Avibactam (CAZ-AVI, Formerly CAZ104) Versus Doripenem Followed by Appropriate Oral Therapy in the Treatment of Complicated Urinary Tract Infections, Including Acute Pyelonephritis, With a Gram Negative Pathogen in Hospitalized Adults
Status: Enrolling
Updated: 3/8/2016
Clinical Research Facility
78
mi
from 43215
Lima, OH
Click here to add this to my saved trials
Ceftazidime-Avibactam Compared With Doripenem Followed by Oral Therapy for Hospitalized Adults With Complicated UTIs (Urinary Tract Infections)
A Phase III, Randomized, Multicenter, Double-Blind, Double Dummy, Parallel Group, Comparative Study to Determine the Efficacy, Safety, and Tolerability of Ceftazidime Avibactam (CAZ-AVI, Formerly CAZ104) Versus Doripenem Followed by Appropriate Oral Therapy in the Treatment of Complicated Urinary Tract Infections, Including Acute Pyelonephritis, With a Gram Negative Pathogen in Hospitalized Adults
Status: Enrolling
Updated:  3/8/2016
Research Site
4063
mi
from 43215
Cordoba,
Ceftazidime-Avibactam Compared With Doripenem Followed by Oral Therapy for Hospitalized Adults With Complicated UTIs (Urinary Tract Infections)
A Phase III, Randomized, Multicenter, Double-Blind, Double Dummy, Parallel Group, Comparative Study to Determine the Efficacy, Safety, and Tolerability of Ceftazidime Avibactam (CAZ-AVI, Formerly CAZ104) Versus Doripenem Followed by Appropriate Oral Therapy in the Treatment of Complicated Urinary Tract Infections, Including Acute Pyelonephritis, With a Gram Negative Pathogen in Hospitalized Adults
Status: Enrolling
Updated: 3/8/2016
Research Site
4063
mi
from 43215
Cordoba,
Click here to add this to my saved trials
CCTG 594: Engagement and Retention in Care for HIV+
CCTG 594: Engagement and Retention in Care for HIV+, A Multicenter Trial of the California Collaborative Treatment Group
Status: Enrolling
Updated:  3/8/2016
University of Southern California
1970
mi
from 43215
Los Angeles, CA
CCTG 594: Engagement and Retention in Care for HIV+
CCTG 594: Engagement and Retention in Care for HIV+, A Multicenter Trial of the California Collaborative Treatment Group
Status: Enrolling
Updated: 3/8/2016
University of Southern California
1970
mi
from 43215
Los Angeles, CA
Click here to add this to my saved trials
CCTG 594: Engagement and Retention in Care for HIV+
CCTG 594: Engagement and Retention in Care for HIV+, A Multicenter Trial of the California Collaborative Treatment Group
Status: Enrolling
Updated:  3/8/2016
Harbor UCLA Medical Center
1980
mi
from 43215
Torrance, CA
CCTG 594: Engagement and Retention in Care for HIV+
CCTG 594: Engagement and Retention in Care for HIV+, A Multicenter Trial of the California Collaborative Treatment Group
Status: Enrolling
Updated: 3/8/2016
Harbor UCLA Medical Center
1980
mi
from 43215
Torrance, CA
Click here to add this to my saved trials
CCTG 594: Engagement and Retention in Care for HIV+
CCTG 594: Engagement and Retention in Care for HIV+, A Multicenter Trial of the California Collaborative Treatment Group
Status: Enrolling
Updated:  3/8/2016
University of California, San Diego
1926
mi
from 43215
San Diego, CA
CCTG 594: Engagement and Retention in Care for HIV+
CCTG 594: Engagement and Retention in Care for HIV+, A Multicenter Trial of the California Collaborative Treatment Group
Status: Enrolling
Updated: 3/8/2016
University of California, San Diego
1926
mi
from 43215
San Diego, CA
Click here to add this to my saved trials
Study of Urethral Mobility in Male Stress Urinary Incontinence Pre- and Post- Placement of Transobturator Sling
Prospective Study of Urethral Mobility in Male Stress Urinary Incontinence Pre- and Post- Placement of Transobturator Sling
Status: Enrolling
Updated:  3/15/2016
Duke Univ Med Ctr
352
mi
from 43215
Durham, NC
Study of Urethral Mobility in Male Stress Urinary Incontinence Pre- and Post- Placement of Transobturator Sling
Prospective Study of Urethral Mobility in Male Stress Urinary Incontinence Pre- and Post- Placement of Transobturator Sling
Status: Enrolling
Updated: 3/15/2016
Duke Univ Med Ctr
352
mi
from 43215
Durham, NC
Click here to add this to my saved trials
Nitrofurantoin and Urinary Tract Infections (UTIs)
A Randomized, Double-blind, Placebo-controlled Trial Examining the Effect of Nitrofurantoin Prophylaxis in Women Performing Clean Intermittent Self-catheterization After Surgery for Urinary Incontinence and/or Pelvic Organ Prolapse
Status: Enrolling
Updated:  3/18/2016
Magee-Womens Hospital
165
mi
from 43215
Pittsburgh, PA
Nitrofurantoin and Urinary Tract Infections (UTIs)
A Randomized, Double-blind, Placebo-controlled Trial Examining the Effect of Nitrofurantoin Prophylaxis in Women Performing Clean Intermittent Self-catheterization After Surgery for Urinary Incontinence and/or Pelvic Organ Prolapse
Status: Enrolling
Updated: 3/18/2016
Magee-Womens Hospital
165
mi
from 43215
Pittsburgh, PA
Click here to add this to my saved trials
Comparison of Burch Urethropexy and Mid-urethral Sling Performed Concomitantly With a Sacral Colpopexy
A Randomized Comparison of Concomitant Incontinence Procedures Performed With Abdominal Sacral Colpopexy: the Burch Versus Mid-urethral Sling Trial
Status: Enrolling
Updated:  3/18/2016
The Mayo Clinic
559
mi
from 43215
Rochester, MN
Comparison of Burch Urethropexy and Mid-urethral Sling Performed Concomitantly With a Sacral Colpopexy
A Randomized Comparison of Concomitant Incontinence Procedures Performed With Abdominal Sacral Colpopexy: the Burch Versus Mid-urethral Sling Trial
Status: Enrolling
Updated: 3/18/2016
The Mayo Clinic
559
mi
from 43215
Rochester, MN
Click here to add this to my saved trials
Conservative Treatment of Postprostatectomy Incontinence
Conservative Treatment of Postprostatectomy Incontinence
Status: Enrolling
Updated:  3/21/2016
University of Alabama at Birmingham
493
mi
from 43215
Birmingham, AL
Conservative Treatment of Postprostatectomy Incontinence
Conservative Treatment of Postprostatectomy Incontinence
Status: Enrolling
Updated: 3/21/2016
University of Alabama at Birmingham
493
mi
from 43215
Birmingham, AL
Click here to add this to my saved trials
Lidocaine Analgesia for Urethral Catheterization in Children
Randomized Clinical Trial of Lidocaine Analgesia for Urethral Catheterization in Children
Status: Enrolling
Updated:  3/28/2016
Seattle Children's Hospital
2005
mi
from 43215
Seattle, WA
Lidocaine Analgesia for Urethral Catheterization in Children
Randomized Clinical Trial of Lidocaine Analgesia for Urethral Catheterization in Children
Status: Enrolling
Updated: 3/28/2016
Seattle Children's Hospital
2005
mi
from 43215
Seattle, WA
Click here to add this to my saved trials
Feasibility Study Evaluating the ParaPatch System
A Multi-center, Open-label, Prospective, Feasibility Study Evaluating the ParaPatch System for the Treatment of Urinary Incontinence and Overactive Bladder
Status: Enrolling
Updated:  3/28/2016
Skyline Urology
1980
mi
from 43215
Sherman Oaks, CA
Feasibility Study Evaluating the ParaPatch System
A Multi-center, Open-label, Prospective, Feasibility Study Evaluating the ParaPatch System for the Treatment of Urinary Incontinence and Overactive Bladder
Status: Enrolling
Updated: 3/28/2016
Skyline Urology
1980
mi
from 43215
Sherman Oaks, CA
Click here to add this to my saved trials
Feasibility Study Evaluating the ParaPatch System
A Multi-center, Open-label, Prospective, Feasibility Study Evaluating the ParaPatch System for the Treatment of Urinary Incontinence and Overactive Bladder
Status: Enrolling
Updated:  3/28/2016
Skyline Urology
1984
mi
from 43215
Torrance, CA
Feasibility Study Evaluating the ParaPatch System
A Multi-center, Open-label, Prospective, Feasibility Study Evaluating the ParaPatch System for the Treatment of Urinary Incontinence and Overactive Bladder
Status: Enrolling
Updated: 3/28/2016
Skyline Urology
1984
mi
from 43215
Torrance, CA
Click here to add this to my saved trials
Post Approval Study of Coaptite® in the Treatment of Female Urinary Incontinence
Status: Enrolling
Updated:  4/5/2016
Clinical Research Facility
624
mi
from 43215
Overland Park, KA
Post Approval Study of Coaptite® in the Treatment of Female Urinary Incontinence
Status: Enrolling
Updated: 4/5/2016
Clinical Research Facility
624
mi
from 43215
Overland Park, KA
Click here to add this to my saved trials
Post Approval Study of Coaptite® in the Treatment of Female Urinary Incontinence
Status: Enrolling
Updated:  4/5/2016
542
mi
from 43215
Wetumpka, AL
Post Approval Study of Coaptite® in the Treatment of Female Urinary Incontinence
Status: Enrolling
Updated: 4/5/2016
542
mi
from 43215
Wetumpka, AL
Click here to add this to my saved trials
Post Approval Study of Coaptite® in the Treatment of Female Urinary Incontinence
Status: Enrolling
Updated:  4/5/2016
Clinical Research Facility
1677
mi
from 43215
Surprise, AZ
Post Approval Study of Coaptite® in the Treatment of Female Urinary Incontinence
Status: Enrolling
Updated: 4/5/2016
Clinical Research Facility
1677
mi
from 43215
Surprise, AZ
Click here to add this to my saved trials
Post Approval Study of Coaptite® in the Treatment of Female Urinary Incontinence
Status: Enrolling
Updated:  4/5/2016
Clinical Research Facility
1947
mi
from 43215
Encinitas, CA
Post Approval Study of Coaptite® in the Treatment of Female Urinary Incontinence
Status: Enrolling
Updated: 4/5/2016
Clinical Research Facility
1947
mi
from 43215
Encinitas, CA
Click here to add this to my saved trials
Post Approval Study of Coaptite® in the Treatment of Female Urinary Incontinence
Status: Enrolling
Updated:  4/5/2016
Clinical Research Facility
1972
mi
from 43215
Los Angeles, CA
Post Approval Study of Coaptite® in the Treatment of Female Urinary Incontinence
Status: Enrolling
Updated: 4/5/2016
Clinical Research Facility
1972
mi
from 43215
Los Angeles, CA
Click here to add this to my saved trials
Post Approval Study of Coaptite® in the Treatment of Female Urinary Incontinence
Status: Enrolling
Updated:  4/5/2016
Clinical Research Facility
1944
mi
from 43215
Oceanside, CA
Post Approval Study of Coaptite® in the Treatment of Female Urinary Incontinence
Status: Enrolling
Updated: 4/5/2016
Clinical Research Facility
1944
mi
from 43215
Oceanside, CA
Click here to add this to my saved trials
Post Approval Study of Coaptite® in the Treatment of Female Urinary Incontinence
Status: Enrolling
Updated:  4/5/2016
Clinical Research Facility
1959
mi
from 43215
Orange, CA
Post Approval Study of Coaptite® in the Treatment of Female Urinary Incontinence
Status: Enrolling
Updated: 4/5/2016
Clinical Research Facility
1959
mi
from 43215
Orange, CA
Click here to add this to my saved trials
Post Approval Study of Coaptite® in the Treatment of Female Urinary Incontinence
Status: Enrolling
Updated:  4/5/2016
2065
mi
from 43215
Templeton, CA
Post Approval Study of Coaptite® in the Treatment of Female Urinary Incontinence
Status: Enrolling
Updated: 4/5/2016
2065
mi
from 43215
Templeton, CA
Click here to add this to my saved trials
Post Approval Study of Coaptite® in the Treatment of Female Urinary Incontinence
Status: Enrolling
Updated:  4/5/2016
Clinical Research Facility
809
mi
from 43215
Celebration, FL
Post Approval Study of Coaptite® in the Treatment of Female Urinary Incontinence
Status: Enrolling
Updated: 4/5/2016
Clinical Research Facility
809
mi
from 43215
Celebration, FL
Click here to add this to my saved trials
Post Approval Study of Coaptite® in the Treatment of Female Urinary Incontinence
Status: Enrolling
Updated:  4/5/2016
Clinical Research Facility
792
mi
from 43215
Orlando, FL
Post Approval Study of Coaptite® in the Treatment of Female Urinary Incontinence
Status: Enrolling
Updated: 4/5/2016
Clinical Research Facility
792
mi
from 43215
Orlando, FL
Click here to add this to my saved trials
Post Approval Study of Coaptite® in the Treatment of Female Urinary Incontinence
Status: Enrolling
Updated:  4/5/2016
Clinical Research Facility
842
mi
from 43215
St. Petersburg, FL
Post Approval Study of Coaptite® in the Treatment of Female Urinary Incontinence
Status: Enrolling
Updated: 4/5/2016
Clinical Research Facility
842
mi
from 43215
St. Petersburg, FL
Click here to add this to my saved trials
Post Approval Study of Coaptite® in the Treatment of Female Urinary Incontinence
Status: Enrolling
Updated:  4/5/2016
Clinical Research Facility
281
mi
from 43215
Berwyn, IL
Post Approval Study of Coaptite® in the Treatment of Female Urinary Incontinence
Status: Enrolling
Updated: 4/5/2016
Clinical Research Facility
281
mi
from 43215
Berwyn, IL
Click here to add this to my saved trials
Post Approval Study of Coaptite® in the Treatment of Female Urinary Incontinence
Status: Enrolling
Updated:  4/5/2016
Clinical Research Facility
282
mi
from 43215
Evanston, IL
Post Approval Study of Coaptite® in the Treatment of Female Urinary Incontinence
Status: Enrolling
Updated: 4/5/2016
Clinical Research Facility
282
mi
from 43215
Evanston, IL
Click here to add this to my saved trials
Post Approval Study of Coaptite® in the Treatment of Female Urinary Incontinence
Status: Enrolling
Updated:  4/5/2016
Clinical Research Facility
248
mi
from 43215
Grand Rapids, MI
Post Approval Study of Coaptite® in the Treatment of Female Urinary Incontinence
Status: Enrolling
Updated: 4/5/2016
Clinical Research Facility
248
mi
from 43215
Grand Rapids, MI
Click here to add this to my saved trials
Post Approval Study of Coaptite® in the Treatment of Female Urinary Incontinence
Status: Enrolling
Updated:  4/5/2016
Clinical Research Facility
395
mi
from 43215
St. Louis, MO
Post Approval Study of Coaptite® in the Treatment of Female Urinary Incontinence
Status: Enrolling
Updated: 4/5/2016
Clinical Research Facility
395
mi
from 43215
St. Louis, MO
Click here to add this to my saved trials
Post Approval Study of Coaptite® in the Treatment of Female Urinary Incontinence
Status: Enrolling
Updated:  4/5/2016
Clinical Research Facility
355
mi
from 43215
Rochester, NY
Post Approval Study of Coaptite® in the Treatment of Female Urinary Incontinence
Status: Enrolling
Updated: 4/5/2016
Clinical Research Facility
355
mi
from 43215
Rochester, NY
Click here to add this to my saved trials
Post Approval Study of Coaptite® in the Treatment of Female Urinary Incontinence
Status: Enrolling
Updated:  4/5/2016
Clinical Research Facility
110
mi
from 43215
Akron, OH
Post Approval Study of Coaptite® in the Treatment of Female Urinary Incontinence
Status: Enrolling
Updated: 4/5/2016
Clinical Research Facility
110
mi
from 43215
Akron, OH
Click here to add this to my saved trials